Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Disease × deltacortene × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Burkitt Lymphoma 3 Leukemia, Biphenotypic, Acute 2 Prostatic Neoplasms 1 Plasmablastic Lymphoma 1 Neuroblastoma 1 Multiple Myeloma 1 Hodgkin Disease 1 Disease 1

Interventions

Cyclophosphamide 2 deltacortene 1 daratumumab 1 carfilzomib 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Dexamethasone 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01190787 2024-01-23

Subcutaneous Velcade Plus Oral Melphalan and Prednisone or Plus Cycloposphamide and Prednisone or Plus Prednisone

European Myeloma Network B.V.

Phase 2 Completed

Disease, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡